| pubmed-article:18438829 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C1415576 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0022417 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0035448 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:18438829 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
| pubmed-article:18438829 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18438829 | pubmed:dateCreated | 2008-5-27 | lld:pubmed |
| pubmed-article:18438829 | pubmed:abstractText | To determine the association of HLA-DRB1, rheumatoid factor (RF), and anti-citrullinated protein antibody (ACPA) status with progression of joint damage in early rheumatoid arthritis (RA) treated according to different treatment strategies. | lld:pubmed |
| pubmed-article:18438829 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18438829 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18438829 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18438829 | pubmed:month | May | lld:pubmed |
| pubmed-article:18438829 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:BreedveldF... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:AllaartC FCF | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:TerwielJ PJP | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:RondayH KHK | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:DijkmansB A... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:HuizingaT W... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:SchreuderG... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:ToesR E MRE | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:de VriesR R... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:KerstensP J... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:VerpoortK NKN | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:Goekoop-Ruite... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:18438829 | pubmed:author | pubmed-author:EwalsJ A P... | lld:pubmed |
| pubmed-article:18438829 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18438829 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:18438829 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18438829 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18438829 | pubmed:pagination | 1293-8 | lld:pubmed |
| pubmed-article:18438829 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:meshHeading | pubmed-meshheading:18438829... | lld:pubmed |
| pubmed-article:18438829 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18438829 | pubmed:articleTitle | Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. | lld:pubmed |
| pubmed-article:18438829 | pubmed:affiliation | VU University Medical Center, Amsterdam, The Netherlands. jeskadvb@xs4all.nl | lld:pubmed |
| pubmed-article:18438829 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18438829 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18438829 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18438829 | lld:pubmed |
